273 related articles for article (PubMed ID: 1883848)
21. Expression and degradation of rat androgen receptor following castration, testosterone replacement and antiandrogens administration: analysis by Western blot and immunohistochemistry.
Suzuki K; Ito K; Kurokawa K; Suzuki T; Shimizu N; Fukabori Y; Honma S; Yamanaka H
Tohoku J Exp Med; 1997 Nov; 183(3):159-72. PubMed ID: 9550125
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders.
Battmann T; Branche C; Bouchoux F; Cerede E; Philibert D; Goubet F; Teutsch G; Gaillard-Kelly M
J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):103-11. PubMed ID: 9569015
[TBL] [Abstract][Full Text] [Related]
23. Changes in the cytoplasmic androgen receptor of rat ventral prostate after administration of androgens, antiandrogens and anabolic steroids.
Ichii S
Endocrinol Jpn; 1980 Aug; 27(4):483-93. PubMed ID: 7460859
[TBL] [Abstract][Full Text] [Related]
24. Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells.
Godoy-Tundidor S; Hobisch A; Pfeil K; Bartsch G; Culig Z
Clin Cancer Res; 2002 Jul; 8(7):2356-61. PubMed ID: 12114440
[TBL] [Abstract][Full Text] [Related]
25. The amino terminus of the human AR is target for corepressor action and antihormone agonism.
Dotzlaw H; Moehren U; Mink S; Cato AC; Iñiguez Lluhí JA; Baniahmad A
Mol Endocrinol; 2002 Apr; 16(4):661-73. PubMed ID: 11923464
[TBL] [Abstract][Full Text] [Related]
26. Interaction of antiandrogen-androgen receptor complexes with DNA and transcription activation.
Warriar N; Pagé N; Koutsilieris M; Govindan MV
J Steroid Biochem Mol Biol; 1993 Dec; 46(6):699-711. PubMed ID: 8274404
[TBL] [Abstract][Full Text] [Related]
27. Deoxyribonucleic acid-binding ability of androgen receptors in whole cells: implications for the actions of androgens and antiandrogens.
Kuil CW; Mulder E
Endocrinology; 1996 May; 137(5):1870-7. PubMed ID: 8612526
[TBL] [Abstract][Full Text] [Related]
28. Effect of a nonsteroidal antiandrogen, flutamide, on androgen receptor dynamics and ornithine decarboxylase gene expression in mouse kidney.
Kontula KK; Seppänen PJ; van Duyne P; Bardin CW; Jänne OA
Endocrinology; 1985 Jan; 116(1):226-33. PubMed ID: 3964747
[TBL] [Abstract][Full Text] [Related]
29. Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor.
Teutsch G; Goubet F; Battmann T; Bonfils A; Bouchoux F; Cerede E; Gofflo D; Gaillard-Kelly M; Philibert D
J Steroid Biochem Mol Biol; 1994 Jan; 48(1):111-9. PubMed ID: 8136296
[TBL] [Abstract][Full Text] [Related]
30. The cellular mechanism of the antiandrogenic action of nomegestrol acetate, a new 19-nor progestagen, on the rat prostate.
Botella J; Paris J; Lahlou B
Acta Endocrinol (Copenh); 1987 Aug; 115(4):544-50. PubMed ID: 3630545
[TBL] [Abstract][Full Text] [Related]
31. Cyproterone acetate prevents translocation of the androgen receptor in the rat prostate.
Brinkmann AO; Lindh LM; Breedveld DI; Mulder E; Van Der Molen HJ
Mol Cell Endocrinol; 1983 Oct; 32(2-3):117-29. PubMed ID: 6227511
[TBL] [Abstract][Full Text] [Related]
32. A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects.
Térouanne B; Tahiri B; Georget V; Belon C; Poujol N; Avances C; Orio F; Balaguer P; Sultan C
Mol Cell Endocrinol; 2000 Feb; 160(1-2):39-49. PubMed ID: 10715537
[TBL] [Abstract][Full Text] [Related]
33. Comparison of in vitro effects of the pure antiandrogens OH-flutamide, Casodex, and nilutamide on androgen-sensitive parameters.
Simard J; Singh SM; Labrie F
Urology; 1997 Apr; 49(4):580-6; discussion 586-9. PubMed ID: 9111629
[TBL] [Abstract][Full Text] [Related]
34. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
Lyng FM; Jones GR; Rommerts FF
Biol Reprod; 2000 Sep; 63(3):736-47. PubMed ID: 10952915
[TBL] [Abstract][Full Text] [Related]
35. Antiandrogens prevent stable DNA-binding of the androgen receptor.
Farla P; Hersmus R; Trapman J; Houtsmuller AB
J Cell Sci; 2005 Sep; 118(Pt 18):4187-98. PubMed ID: 16141232
[TBL] [Abstract][Full Text] [Related]
36. ICI 176,334: a novel non-steroidal, peripherally selective antiandrogen.
Furr BJ; Valcaccia B; Curry B; Woodburn JR; Chesterson G; Tucker H
J Endocrinol; 1987 Jun; 113(3):R7-9. PubMed ID: 3625091
[TBL] [Abstract][Full Text] [Related]
37. Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors.
Berrevoets CA; Veldscholte J; Mulder E
J Steroid Biochem Mol Biol; 1993 Dec; 46(6):731-6. PubMed ID: 8274406
[TBL] [Abstract][Full Text] [Related]
38. Non-steroidal antiandrogens act as AF-1 agonists under conditions of high androgen-receptor expression.
Fuse H; Korenaga S; Sakari M; Hiyama T; Ito T; Kimura K; Kato S
Prostate; 2007 May; 67(6):630-7. PubMed ID: 17342748
[TBL] [Abstract][Full Text] [Related]
39. Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism.
Kelce WR; Lambright CR; Gray LE; Roberts KP
Toxicol Appl Pharmacol; 1997 Jan; 142(1):192-200. PubMed ID: 9007049
[TBL] [Abstract][Full Text] [Related]
40. Relative potency of antiandrogens with reference to intracellular testosterone in the rat prostate.
Kondo Y; Homma Y; Aso Y; Kawabe K; Mieda M; Takahashi H
Prostate; 1996 Sep; 29(3):146-52. PubMed ID: 8827082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
